SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-23-039014
Filing Date
2023-11-01
Accepted
2023-11-01 16:55:29
Documents
7
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 23794
2 ex5-1.htm EX-5.1 117215
3 ex10-1.htm EX-10.1 229919
4 ex5-1_001.jpg GRAPHIC 9159
5 ex5-1_002.jpg GRAPHIC 7705
6 ex5-1_003.jpg GRAPHIC 3423
7 ex5-1_004.jpg GRAPHIC 26071
  Complete submission text file 0001493152-23-039014.txt   436176
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 231369002
SIC: 2836 Biological Products, (No Diagnostic Substances)